RNA interference targeting the R2 subunit of ribonucleotide reductase inhibits growth of tumor cells in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RNA interference targeting the R2 subunit of ribonucleotide reductase inhibits growth of tumor cells in vitro and in vivo

Published:2007-04 Issue:4 Volume:18 Page:377-388
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Avolio Tina M.,Lee Yoon,Feng Ningping,Xiong Keyong,Jin Hongnan,Wang Ming,Vassilakos Aikaterini,Wright Jim,Young Aiping

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference85 articles.

1. RNA interference: traveling in the cell and gaining functions;Cerutti;Trends Genet,2003

2. Post-transcriptional gene silencing across kingdoms;Cogoni;Curr Opin Genet Dev,2000

3. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans;Napoli;Plant Cell,1990

4. mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD;Ketting;Cell,1999

5. Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi;Sijen;Nature,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present;Biomolecules;2022-06-10

2. Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2;International Journal of Oncology;2019-02-28

3. Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?;Journal of Cancer Research and Clinical Oncology;2017-06-17

4. Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery;Colloids and Surfaces B: Biointerfaces;2015-11

5. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies;Oncogene;2014-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3